SCHEMBL5694342

SCHEMBL5694342

CC(=O)OC(=O)c1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
L3MBTL1 Q9Y468 5/20 0.53
LMNA P02545 1/20 0.53
NAPRT Q6XQN6 1/20 0.53
P4HTM Q9NXG6 1/20 0.53
KDM4E B2RXH2 4/20 0.51
MAPT P10636 3/20 0.51
POLB P06746 1/20 0.51
KMT2A Q03164 3/20 0.48
PKM P14618 3/20 0.48
MEN1 O00255 1/20 0.48
GSK3B P49841 1/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
APP P05067 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1228223 0.88 CES2 (0.64) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL31633615 0.88 CES2 (0.64) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL1831093 0.85 ALDH1A1 (0.58) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL19993973 0.85 ALDH1A1 (0.58) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL27505714 0.82 L3MBTL1 (0.61) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL5242228 0.81 KDM4E (0.56) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL14609300 0.81 ALDH1A1 (0.53) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL9221780 0.81 CES2 (0.55) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL29289773 0.80 ALDH1A1 (0.52) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL29576494 0.80 KDM4E (0.68) ALDH1A1CES2CES1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112118830-B Solid dosage forms with high active agent loading 比利时胶囊公司 2023-11-10 CN disclosed
CN-115697336-A Pharmaceutical preparation and use thereof 奥尔德拉医疗公司 2023-02-03 CN disclosed
CN-112118830-A High active agent loading solid dosage forms 比利时胶囊公司 2020-12-22 CN disclosed
CN-109503469-B Preparation method of 2-acetylpyridine 浙江理工大学 2020-08-04 CN disclosed
CN-110996913-A Novel oral formulation of belinostat 欧恩科斯欧公司 2020-04-10 CN disclosed
CN-109503469-A A kind of preparation method of 2- acetylpyridine 浙江理工大学 2019-03-22 CN disclosed
EP-1643948-A1 DIFFUSION LAYER MODULATED SOLIDS Pharmacia & Upjohn Company LLC (US) 2006-04-12 EP disclosed
US-20050042291-A1 Diffusion layer modulated solids HAWLEY MICHAEL (US) 2005-02-24 US disclosed
WO-2005004763-A1 DIFFUSION LAYER MODULATED SOLIDS PHARMACIA & UPJOHN COMPANY LLC. (US) 2005-01-20 WO disclosed